Abbott Laboratories

NYSE:ABT  
109.44
+3.23 (+3.04%)
4:02:27 PM EDT: $108.43 -1.01 (-0.92%)
Products, Community

Abbott Laboratories, On Powdered Formulas Recall, Says Fssai In India Was Informed And Due Process Was Followed And Noted - Spokesperson

Published: 05/20/2022 13:10 GMT
Abbott Laboratories (ABT) - Abbott Laboratories, on Powdered Formulas Recall, Says Fssai in India Was Informed and Due Process Was Followed and Noted - Spokesperson.
Voluntary Recall in India Impacted Alimentum and Elecare- Spokesperson.
No Other Abbott Nutrition Products – Or Similac Products – Distributed in India Were Affected by the Recall- Spokesperson.
Abbott Laboratories' Recall Has Been Completed in India - Spokesperson.